The role of metabolic therapy with trimetazidine in effort tolerance in patients with ischemic heart disease
Aim To investigate whether or not additional treatment of ischemic heart disease with trimetazidine could improve effort tolerance and overall quality of life of patients with ischemic heart disease. Methods The study included 200 patients with ischemic heart disease. The sample was divided into 2...
Main Authors: | Una Suljić, Besim Prnjavorac, Tamer Bego, Maja Malenica, Tanja Dujić, Irfan Prnjavorac, Adlija Čaušević, Lejla Šaranović |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Association of Zenica-Doboj Canton
2018-08-01
|
Series: | Medicinski Glasnik |
Subjects: | |
Online Access: | http://ljkzedo.ba/wordpress/wp-content/uploads/2018/07/18-Suljic-965-A.pdf |
Similar Items
-
Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus
by: Sabina Semiz, et al.
Published: (2010-11-01) -
EVALUACIÓN FUNCIONAL CARDIOVASCULAR EN HIPERTENSOS TRATADOS CON ENALAPRIL DURANTE 6 MESES / Functional assessment in hypertensive patients treated with enalapril for 6 months
by: Francisco Rodríguez Martorell, et al.
Published: (2012-07-01) -
Effects of the PPARG gene polymorphisms on markers of obesity and the metabolic syndrome in Bosnian subjects
by: Dujić Tanja, et al.
Published: (2014-01-01) -
Association of PPARG and LPIN1 gene polymorphisms with metabolic syndrome and type 2 diabetes
by: Tamer Bego, et al.
Published: (2011-02-01) -
Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina
by: Sabina Semiz, et al.
Published: (2011-02-01)